Health Related Articles
Chile leader visits ailing 14 year-old who wants to end her life
Chile's President Michelle Bachelet on Saturday visited a 14-year-old girl suffering from cystic fibrosis who made a heart-wrenching video appeal to be allowed to end her life. Valentina Maureira had addressed Bachelet personally in the message, which she recorded with a smartphone and uploaded to YouTube from her hospital bed without her parents knowledge. Maureira is in "stable" condition from cystic fibrosis, an incurable genetic disorder that attacks the lungs and other vital organs, making it difficult to breath and causing a host of other symptoms. Her message has been viewed thousands of times on social networks, igniting debate over euthanasia in Chile, where it is forbidden by law.
Herbalife cuts pay of CEO Johnson 36 percent after missed targets
Herbalife Ltd cut the pay of Chief Executive Michael Johnson 36 percent for 2014 after the nutrition and weight loss company failed to meet performance goals set for him and other top executives, according to a securities filing on Friday. Herbalife said Johnson, who is also chairman, received total compensation of $6.73 million last year, down from $10.5 million in 2013, mainly because he did not receive the incentive plan compensation of $3.7 million he got the prior year. Herbalife has been closely watched since activist investor William Ackman accused the company of running a pyramid scheme in 2012, while rival investor Carl Icahn became the company's biggest owner in 2013. Herbalife, being investigated by state and federal regulators, has denied Ackman's charges.
Singapore's Lee Kuan Yew remains in intensive care, health improves slightly
Lee Kuan Yew, Singapore's first prime minister, remains in intensive care after being admitted to hospital with severe pneumonia but his condition has improved slightly, the government said on Saturday. Lee, who turned 91 last September, has been in hospital since Feb. 5. "Lee Kuan Yew's condition has improved slightly. He remains sedated and on mechanical ventilation in the ICU (intensive care unit)," said a statement from the office of the current prime minister, adding that Lee was continuing with his antibiotics.
U.S., Liberia kick off trial of Ebola drug ZMapp
By Reuters Staff CHICAGO (Reuters) - U.S. and Liberian researchers have started a clinical trial to test the safety and effectiveness of Mapp Biopharmaceutical Inc's Ebola drug ZMapp, an experimental treatment that has already been tried in a handful of Ebola patients, including two U.S. missionaries. The trial, a joint effort by the Liberian government and the National Institute of Allergy and Infectious Diseases (NIAID), will be conducted in Liberia and the United States among adults and children infected with Ebola, NIAID said on Friday.
Doctors should take lead in push to curb climate change: experts
By Kyle Plantz LONDON (Thomson Reuters Foundation) - Doctors should take the lead in supporting political efforts to cut the pace of climate change and encouraging more people to see the problem as a crucial issue for public health, experts say. With the 68th World Health Assembly coming up in May in Geneva, countries are poised to adopt the world's first resolution on air pollution and health, in an effort to reduce premature deaths linked to air pollution. Studies have found that air pollution can worsen a variety of health problems, from heart disease to strokes, said Carlos Dora, coordinator of public health and the environment at the World Health Organization (WHO).
U.S. judge denies Ranbaxy bid to reinstate approvals for Valcyte, Nexium copies
A U.S. federal judge has denied Indian generic drugmaker Ranbaxy Laboratories Ltd's bid to reinstate approvals granted to it to launch the first copies of the heartburn drug Nexium and the antiviral Valcyte, a court document showed. Judge Beryl Howell of the United States District Court for the District of Colombia on Friday also blocked Ranbaxy's plea for a preliminary injunction to halt Teva Pharmaceutical Industries Ltd, Endo International Plc and Dr Reddy's Laboratories Ltd from launching copies of the two drugs. The court decision came after Ranbaxy sued the U.S. Food and Drug Administration in November for pulling approvals that would have allowed the Indian firm to launch the first copies of Roche's Valcyte and AstraZeneca Plc's Nexium. FDA had said its earlier decision granting the approvals was "in error" as Ranbaxy's plants at the time were not compliant with the U.S. regulator's manufacturing quality standards.
This is your source for easy-to-use information on the most popular drugs and medications. It's the place to learn more
about prescription drugs and the correct use of them. DrugInformationOnline.org provides detailed information on prescription
drugs and over the counter medications including their description, side effects, dosage, use, precautions, interactions,
storage, and other pharmaceutical advice.
Cymbalta (Duloxetine HCl)
Lexapro (Escitalopram Oxalate)
Plavix (Clopidogrel Bisulfate)
Valtrex (Valacyclovir Hydrochloride)
There are risks and hazards for consumers if they turn to internet pharmacies simply to save money.
DrugInformationOnline.org reminds you to find a licensed or accredited online pharmacy that require a valid prescription
and complies with safety guidelines. We recommend TOP featured Canadian online pharmacies to ensure consumers have access
to high-quality drugs and medications at the most reasonable prices.